142 is a clinical research site located in Columbus, Ohio, United States 31904.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
142 has participated in 1 clinical trials.
Therapeutic areas: Paroxysmal Supraventricular Tachycardia.
Sponsors: Milestone Pharmaceuticals Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
142 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
142 has 1 clinical trials on record. Their work covers Paroxysmal Supraventricular Tachycardia.
142 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.